Publications
Click on a title to open the PDF. You will need Adobe Acrobat Reader installed on your computer to view the PDF files. If you do not have Adobe Acrobat Reader, you can download it from here.| 106 | Infection and irritability. | |
| Lea R, Whorwell PJ. | Gut 2002;51:305-6. | |
| 107 | A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmography. | |
| Reilly BP, Bolton MP, Lewis MJ, Houghton LA, Whorwell PJ. | Physiological Measurement 2002;23:661-70. | |
| 108 | The rectum: a window on irritable bowel syndrome? | |
| Coremans G, Azpiroz F, Collins S, Dapoigny M, Mull-Lissner SA, Pace F, Smout A, Stockbrugger RW, Whorwell PJ. |
Digestion 2002;65:238-49. | |
| 109 | Functional Constipation. | |
| Lea R, Whorwell PJ, Kiff E. | Journal of Functional Syndromes 2002;2:86-99. | |
| 110 | Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? | |
| Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. |
Gut 2003;52:91-3. | |
| 111 |
Gut focused hypnotherapy normalises disordered rectal sensitivity in patients with irritable bowel syndrome. |
|
| Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ. |
Alimentary Pharmacology and Therapeutics 2003;17:635-42. | |
| 112 |
Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. | |
| Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. |
Gut 2003;52:663-70. | |
| 113 |
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. |
|
| Hungin AP, Whorwell PJ, Tack J, Mearin F. | Alimentary Pharmacology and Therapeutics 2003;17:643-50. | |
| 114 | Long term benefits of hypnotherapy for irritable bowel syndrome. | |
| Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. | Gut 2003;52:1623-9. | |
| 115 |
Consensus report: clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. |
|
| Corazziari E, Bytzer P, Delvaux M, Holtmann G, Malagelada JR, Morris J, Muller-Lissner S, Spiller RC, Tack J, Whorwell PJ. |
Alimentary Pharmacology and Therapeutics 2003;18:569-80. | |
| 116 | Role of alimentation in irritable bowel syndrome. | |
| Dapoigny M, Stockbrugger RW, Azpiroz F, Collins S, Coremans G, Muller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell PJ. |
Digestion 2003;67:225-33. | |
| 117 | Irritable bowel syndrome or endometriosis, or both? | |
| Lea R, Whorwell PJ. | European Journal of Gastroenterology and Hepatology 2003;15:1131-3. | |
| 118 |
Symptomatic inflammatory bowel disease in remission - it could be irritable bowel syndrome. |
|
| Whorwell PJ. | Gastrointestinal Inflammation and Disturbed Gut Function: The Challenge of New Concepts. Falk Symposium. No 130 2003;53-56. |
|
| 119 | New insights into the psychosocial aspects of irritable bowel syndrome. | |
| Lea R, Whorwell PJ. | Curr Gastroenterol Rep 2003;5:343-50. | |
| 120 | Tegasterod for the treatment of irritable bowel syndrome. | |
| Evans BW, Clark W, Moore D, Whorwell PJ. | Cochrane database Syst Rev 2004;1:CD003960. | |